Natco Pharma
BSE: 524816 | NSE: NATCOPHARM | ISIN: INE987B01018 | Pharmaceuticals
 |
 |
Yearly Results of Natco Pharma |
------------------- in Rs. Cr. ------------------- |
| ||||||||||
|
||||||||||
| Mar '05 | Mar '06 | Mar '07 | Mar '08 | Mar '09 | ||||||
|
||||||||||
| Sales Turnover | 160.01 | 160.79 | 180.22 | 227.88 | 286.07 | |||||
| Other Income | 21.38 | 32.47 | 36.66 | 22.75 | -- | |||||
| Total Income | 181.39 | 193.26 | 216.88 | 250.63 | 286.07 | |||||
| Total Expenses | 162.27 | 149.89 | 163.78 | 188.19 | 212.71 | |||||
| Operating Profit | -2.26 | 10.90 | 16.44 | 39.69 | 73.36 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | -- | -- | 9.20 | 4.14 | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 19.12 | 43.37 | 53.10 | 62.44 | 73.36 | |||||
| Interest | 12.53 | 9.69 | 5.69 | 8.50 | 13.73 | |||||
| PBDT | 6.59 | 33.68 | 47.41 | 63.14 | 63.77 | |||||
| Depreciation | 5.84 | 6.64 | 7.61 | 8.59 | 10.35 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 0.75 | 27.04 | 39.80 | 54.55 | 53.42 | |||||
| Tax | -0.81 | 3.43 | 9.33 | 14.50 | 10.68 | |||||
| Net Profit | 1.56 | 23.61 | 30.47 | 40.05 | 42.74 | |||||
| Prior Years Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share | 0.60 | 8.69 | 11.02 | 14.28 | 15.24 | |||||
| Book Value | -- | -- | -- | -- | -- | |||||
| Equity | 26.16 | 27.17 | 27.64 | 28.04 | 28.04 | |||||
| Reserves | 66.69 | 120.33 | 152.50 | -- | -- | |||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore Natco Pharma connections | ||||||||||
| ||||||||||
